Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Trinity Industries
TRN
$2.5B
| $3.71M | ﹤0.01% |
122,885
+28,564
| +30% | +$816K |
|
1927
CALL
LyondellBasell Industries
LYB
$19.6B
| $3.71M | ﹤0.01% |
40,200
| – | – |
|
1928
Leggett & Platt
LEG
$1.37B
| $3.7M | ﹤0.01% |
89,810
-115,704
| -56% | -$5.03M |
|
|
IMGN
1929
DELISTED
Immunogen Inc
IMGN
| $3.7M | ﹤0.01% |
498,324
+292,628
| +142% | +$1.82M |
|
|
COOP
1930
DELISTED
Mr. Cooper
COOP
| $3.69M | ﹤0.01% |
88,745
+14,588
| +20% | +$614K |
|
1931
CALL
Accenture
ACN
$101B
| $3.69M | ﹤0.01% |
8,900
| – | – |
|
1932
Amkor Technology
AMKR
$12.6B
| $3.69M | ﹤0.01% |
148,634
-431
| -0.3% | -$10K |
|
1933
The Bancorp
TBBK
$2.96B
| $3.68M | ﹤0.01% |
145,338
+27,838
| +24% | +$802K |
|
1934
Atara Biotherapeutics
ATRA
$77M
| $3.67M | ﹤0.01% |
9,328
-2,799
| -23% | -$1.18M |
|
1935
CALL
eBay
EBAY
$47.6B
| $3.66M | ﹤0.01% |
55,000
| – | – |
|
1936
PUT
Teva Pharmaceuticals
TEVA
$40.2B
| $3.65M | ﹤0.01% |
455,200
+434,000
| +2,047% | +$3.92M |
|
1937
PUT
HP
HPQ
$24.8B
| $3.64M | ﹤0.01% |
96,700
+89,200
| +1,189% | +$2.92M |
|
1938
MGE Energy Inc
MGEE
$3.02B
| $3.64M | ﹤0.01% |
44,222
+22,912
| +108% | +$1.76M |
|
|
NVO
1939
Novo Nordisk
NVO
$208B
| $3.63M | ﹤0.01% |
64,896
-10,160
| -14% | -$550K |
|
1940
Hecla Mining
HL
$9.68B
| $3.63M | ﹤0.01% |
694,540
+406,119
| +141% | +$2.27M |
|
1941
PUT
Dollar Tree
DLTR
$24.9B
| $3.63M | ﹤0.01% |
25,800
-3,900
| -13% | -$474K |
|
|
PGM
1942
DELISTED
iPath Series B Bloomberg Platinum Subindex Total ReturnSM ETN
PGM
| $3.62M | ﹤0.01% |
80,000
| – | – |
|
1943
Astrana Health
ASTH
$1.78B
| $3.62M | ﹤0.01% |
49,233
+19,146
| +64% | +$1.57M |
|
1944
Imperial Oil
IMO
$61.1B
| $3.61M | ﹤0.01% |
100,094
-648,239
| -87% | -$22.3M |
|
1945
John Wiley & Sons Class A
WLY
$2.7B
| $3.61M | ﹤0.01% |
63,098
+12,848
| +26% | +$695K |
|
|
SPR
1946
DELISTED
Spirit AeroSystems
SPR
| $3.61M | ﹤0.01% |
83,755
+11,686
| +16% | +$501K |
|
1947
Eagle Bancorp
EGBN
$849M
| $3.6M | ﹤0.01% |
61,705
+17,921
| +41% | +$1.04M |
|
1948
iShares MSCI Europe Small-Cap ETF
IEUS
$181M
| $3.59M | ﹤0.01% |
51,596
+11,766
| +30% | +$821K |
|
1949
Global X Lithium & Battery Tech ETF
LIT
$1.5B
| $3.58M | ﹤0.01% |
42,431
-10,713
| -20% | -$950K |
|
1950
Patrick Industries
PATK
$2.77B
| $3.58M | ﹤0.01% |
66,594
+18,864
| +40% | +$1.01M |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.